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In the last three decades, few single biological ob-
jects have attracted as much general interest as the
purple protein, bacteriorhodopsin. Although it oc-
curs in the membranes of an obscure organism that
lives in the hypersaline lakes found only in remote
and unusual locations, and until recently had no
evolutionary connection with any other known eu-
bacterial or eukaryotic protein, it rapidly became the
subject of intense research, and has remained at the
center of attention ever since. The reason is that this
small retinal-containing protein has long promised to
be the Rosetta stone for deciphering how ion pumps
work.
As a very large number of investigators realized
soon after its discovery, in many respects, bacterio-
rhodopsin is an ideal transport protein for study. It
is available in large quantities, can be puri¢ed with
trivial e¡ort, is extraordinarily stable, and most im-
portant of all, the simple process of photoisomeriza-
tion of the all-trans retinal to 13-cis is able to drive
the e⁄cient translocation of a proton across the
membrane. The desire to understand bacteriorho-
dopsin brought out the best in all the technologies
either available or waiting to be developed. It was
one of the ¢rst membrane proteins in which extensive
mutagenesis was carried out, ¢rst in a heterologous
then in a homologous expression system. It was one
of the ¢rst proteins to be studied with infrared, Ram-
an and solid-state nuclear magnetic resonance spec-
troscopy, methods of extraordinary speci¢city and
exquisite sensitivity. Instrumentation for time-re-
solved measurements at visible wavelengths has
been developed expressly for bacteriorhodopsin,
with resolutions that reach into the fs range. Electron
di¡raction, now widely used, cut its teeth on solving
the structure of this protein in its naturally occurring
two-dimensional crystalline lattice. More recently,
three-dimensional bacteriorhodopsin crystals have
been grown that di¡ract unusually well, uniquely
for an integral membrane protein, otherwise notori-
ously di⁄cult to crystallize. In short, the over 5000
publications on bacteriorhodopsin have helped di-
rectly, or inspired by example, the entire ¢eld of
membrane proteins.
Research on bacteriorhodopsin has many facets,
including interesting and important questions con-
cerning the photochemistry of the retinal, protein
folding, insertion, assembly into a naturally occur-
ring hexagonal crystalline array, stability, conforma-
tional £uctuations and substates, and others, but the
most urgent question probably concerns its function
as a transmembrane pump. There have been times in
the past when the solution to how bacteriorhodopsin
transports protons seemed to be near, only to be
frustrated by contradictions and controversies. With
the rising expectations in the ¢eld of all membrane
proteins, it is now clear for bacteriorhodopsin also
that a full and comprehensive mechanism will not be
available until we have a detailed structural under-
standing of the protein, as well as its many inter-
mediate states in the transport cycle. To many, this
stage seems tantalizingly near. Given the recent rapid
progress in this direction, from both crystallographic
and spectroscopic studies, are we being too optimis-
tic when we expect that the main questions of the
bacteriorhodopsin problem will soon be solved?
We now know that the extracellular half of the
protein contains many water molecules that form,
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together with polar protein residues, a three-dimen-
sional hydrogen-bonded network. A water molecule
hydrogen-bonded to the protonated retinal Schi¡
base and to two anionic aspartates stabilizes the sep-
arated charges at the active site. The cytoplasmic
half, in contrast, contains only a few water mole-
cules, and acts as a hydrophobic barrier. Photoiso-
merization of the retinal to 13-cis initiates changes
that begin near the Schi¡ base and spread to the rest
of the protein over the about 10 ms duration of the
photocycle. The result of these ¢rst local, and then
later larger-scale, conformational changes is to
change the pK of acidic residues, in a sequence
now being described in detail. As a consequence of
the changes in proton a⁄nities, the proton occupan-
cies of these residues change in a way that generates
the step by step travel of a proton across the protein,
from the cytoplasmic to the extracellular side. The
most important of these events, that impart a direc-
tion to the transport, are the protonation of Asp-85
to the extracellular side of the Schi¡ base and the
deprotonation of Asp-96 to the cytoplasmic side.
Understanding these photocycle events has provided
profound insights into the transport process, but it
should be evident from the collection of articles in
this issue that important questions are still unan-
swered. It should be evident also from the articles,
however, that the most searching questions are, or
can be, asked more speci¢cally than ever before. In
the following, I give my impressions of the contro-
versies of today (and tomorrow).
Many of the articles in this issue contain novel and
original suggestions concerning the nature of the
‘protonation switch’, that decides the direction of
proton transfers and ultimately accounts for the vec-
torial transport. I am intrigued that, even at this
stage of our understanding of the protein, all of these
proposed models are di¡erent. This raises profound
questions as to how much we really know about this
crucial aspect of the transport cycle. Does the switch
reside in a single bond rotation of the retinal, that
allows it to relax from a strongly distorted con¢gu-
ration once the electrostatic constrains are removed
when a proton passes from the Schi¡ base to Asp-
85? Does it need to be an unidirectional reaction? Is
the switch function performed, alternatively, by a
mobile water at the Schi¡ base, carrying a proton
across the barrier? Is the direction of the switch, ex-
tracellular to cytoplasmic and back, decided only at
the Schi¡ base, or do the varying proton a⁄nities
and proton transfer pathways make a greater di¡er-
ence? Does it make sense, in this case, to distinguish
a single switch step, separate and independent of
other photocycle steps, or is the ‘switch’ simply the
directional aspect of all photocycle reactions?
The articles in this issue raise many other, more
mechanistic, questions as well. Neither the proton
release to the extracellular surface nor the proton
uptake from the cytoplasmic surface is well under-
stood. As to the former, where does the released
proton originate? As to the latter, how is the pK of
the recipient of the proton, Asp-96, modulated over
what amounts to at least 5 pH units? Does bound
water dissociate and yield a mobile hydroxyl ion, at
any step of the transport cycle? Given the fact that it
is di⁄cult to dissociate H2O (in water less than one
out of 108 molecules is dissociated), at which site in
the protein would dissociation be most likely? If a
hydroxyl ion instead of a proton is moved at the
Schi¡ base, should bacteriorhodopsin be called a hy-
droxyl pump, analogous to the chloride ion pump,
halorhodopsin? What is the role of the observed
large-scale conformational change at the cytoplasmic
surface? Indeed, does it have any functional role or is
it simply a (not even inevitable) consequence of more
subtle conformational shifts of direct functional sig-
ni¢cance? Does the analogy of bacteriorhodopsin
with sensory rhodopsins re£ect mainly the require-
ment of a large-scale conformational change for sig-
naling, but then how do we explain that when the
means for signaling are removed, some sensory rho-
dopsins transport protons?
In the last years, much progress has been made in
the study of other transmembrane pumps, such as
the cytochrome c oxidase and the mitochondrial
ATPase, as well. In a larger sense, it is legitimate
to ask whether, in the light of what we know now,
the questions of bacteriorhodopsin are still of general
interest. I suggest that bacteriorhodopsin is regarded
as a stripped-down ion pump, where complications
from the chemistry of the driving reaction, and a
proton stoichiometry greater than one, are absent.
Although the problems that remain in such a simpli-
¢ed protein still loom large, the vitality and imagi-
nation displayed in the articles in this issue promise
that they will be attacked with vigor. Once the con-
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troversies and contradictions now evident in the bac-
teriorhodopsin ¢eld are settled, the acid/base chem-
istry and the participation of hydrogen-bonded
water, that underlie the translocation of protons,
will ¢nally be understood. This seems like a worthy
goal, and in the general interest.
There are many contributors to the bacteriorho-
dopsin ¢eld. My unpalatable duty as an editor was
to limit the number of reviews to something manag-
able, and many investigators with considerable ac-
complishments could not be included. Some of
them have promised articles but could not contribute
them in the end, others overlapped too much with
newer-generation researchers who were given prefer-
ence where possible, and still others have research
directions not exactly in line with the focus on struc-
tural issues in this issue. Their contributions should
be acknowledged, nevertheless. They include: U.
Alexiev, P.A. An¢nrud, G.H. Atkinson, E. Bamberg,
D. Bashford, R.R. Birge, R.A. Bogomolni, M.S.
Braiman, S.E. Braslavsky, R.H. Callender, R.K.
Crouch, W.J. De Grip, H.J.M. De Groot, A.K. Di-
oumaev, A. De¤r, R. Diller, L.A. Drachev, T.G.
Ebrey, M.A. El-Sayed, M. Engelhard, D. Engelman,
Y. Fujiyoshi, W. Ga«rtner, K. Gerwert, R. Govindjee,
F.M. Gon‹i, G. Groma, M. Gutman, S. Hashimoto,
J. Heberle, R.W. Hendler, B. Honig, W. Hubell, T.
Kakitani, L. Keszthelyi, H.G. Khorana, D. Kliger,
Y. Kimura, T. Kitagawa, T. Kouyama, K. Koyama,
R.S.H. Liu, J. Lugtenburg, A. Maeda, R.A. Mathies,
Y. Mukohata, K. Nakanishi, R. Needleman, D. Oes-
terhelt, P. Ormos, H. Otto, M. Ottolenghi, E. Pa-
dros, R. Pomes, R. Renthal, J.-L. Rigaud, K.J.
Rothschild, H.J. Sass, C. Scharnagl, M. Sheves, Y.
Shichida, Y.-K. Shin, F. Siebert, V.P. Skulachev,
S.O. Smith, H.-J. Steinho¡, M. Stockburger, W.
Stoeckenius, H. Takei, T.E. Thorgeirsson, J. Tittor,
Zs. Tokaji, F. Tokunaga, A. Watts, G. Zaccai, L.
Zima¤nyi, their coworkers, and others.
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